Medpage Today on MSN12h
Risk-Reducing Surgery May Benefit BRCA Carriers With Early-Onset Breast Cancer
Among more than 5,000 patients followed for a median of roughly 8 years, bilateral risk-reducing mastectomy (RRM) was ...
Cancer therapy shows long-term survival benefits for patients with high-risk, BRCA-positive breast cancer in trial
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to ...
Medscape21h
Olaparib Continues to Protect Patients From High-Risk Cancer Recurrences
The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...
Pharmabiz18m
AstraZeneca & Merck announce OlympiA phase 3 trial of Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer
AstraZeneca & Merck announce OlympiA phase 3 trial of Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer: Rahway, New Jersey Friday, Dec ...
News Medical1d
Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients
Patients with high-risk, BRCA-positive breast cancer who received olaparib (Lynparza) after standard treatment continued to have better survival outcomes than those who received placebo after a median ...
pharmaphorum23h
Lynparza boosts long-term survival in early breast cancer
AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...
Armed robbery in Revesby1d
PARP Inhibitors Boost Survival in High-Risk BRCA Breast Cancer
Patients with high-risk, BRCA-positive breast cancer who received olaparib after standard treatment continued to have better ...
Targeted Oncology1d
6-Year Data Sustain Adjuvant Olaparib Benefit in BRCA1/2+, HER2- Breast Cancer
Adjuvant olaparib continued to show a strong efficacy benefit in patients with BRCA1/2 mutation–positive, HER2-negative ...
News Medical1d
Risk-reducing surgeries provide benefits for young BRCA-mutation carriers
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...
BRCA-mutation carriers with history of early-onset breast cancer may benefit from risk-reducing surgery
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral ...
cancerhealth22h
BRCA Mutation Carriers With Early-Onset Breast Cancer May Benefit From Risk-Reducing Surgery
Women who underwent bilateral mastectomy or removal of ovaries and Fallopian tubes had lower rates of recurrence, ovarian ...
EurekAlert!2d
BRCA-mutation carriers with a history of early-onset breast cancer may benefit from risk-reducing surgery
Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...